Healthtech Investors & VC Firms in China

267 firms in this list, with a median first check of $1M. 44 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Redpoint Ace Ventures 5 people	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
Jeneration Capital 4 people	Grand Cayman, Ky	CN	Series B–Growth	—	+ Add to CRM
Oriza Holdings 2 people	Suzhou	CN	Seed–Series C	—	+ Add to CRM
Advantech Capital 3 people	Camana Bay	CN	Growth	—	+ Add to CRM
Fosun RZ Capital	Beijing	CN	Seed–Growth	—	+ Add to CRM
GL Ventures	Beijing	CN	Seed–Growth	—	+ Add to CRM
Cybernaut Investment Group 2 people	Shanghai	CN	Series A–Series B	—	+ Add to CRM
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd. 2 people	Shenzhen	CN	Seed–Series B	—	+ Add to CRM
CPE	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
Yonghua Capital	Shanghai	CN	Seed–Series B	—	+ Add to CRM
Plug and Play China 1 person	Shanghai	CN	Pre-Seed–Growth	—	+ Add to CRM
Shanghai STVC Group 1 person	Shanghai	CN	Seed–Growth	—	+ Add to CRM
China Merchants Capital	Shenzhen	CN	Growth–Late Stage	—	+ Add to CRM
3H Health Investment	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
CICC	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
Co-Stone Capital	Shenzhen	CN	Seed–Growth	—	+ Add to CRM
Haier HOPE / HCH innovation platform	Qingdao	CN	Pre-Seed–Growth	—	+ Add to CRM
SAIF Partners China	Beijing	CN	Seed–Growth	—	+ Add to CRM
SDIC Venture Capital / SDIC Fund Management	Beijing	CN	Seed–Growth	—	+ Add to CRM
ZSVC	Beijing	CN	Seed–Series B	—	+ Add to CRM
General Atlantic 500 people · Leads rounds	New York	US	Series B–Late Stage	$10M – $1B	+ Add to CRM
New Enterprise Associates (NEA) 81 people · Leads rounds	Menlo Park	US	Seed–Late Stage	$200K – $40M	+ Add to CRM
SOSV 81 people · Leads rounds	New York	US	Pre-Seed–Series B	$30K – $550K	+ Add to CRM
F-Prime Capital 110 people · Leads rounds	Cambridge	US	Pre-Seed–Series C	$3M – $10M	+ Add to CRM